Navigation Links
Peregrine Reports Data Showing Bavituximab's Potential to Shrink Prostate Tumors
Date:9/7/2007

most commonly diagnosed cancer in men, accounting for 30 percent of all male cancers, and prostate cancer is second only to lung cancer as a leading cause of male cancer deaths. Currently, there is no cure for locally advanced or metastatic prostate cancer.

"We are delighted that bavituximab shrank resistant human prostate tumors in this study, an important new sign of its potential anti-cancer efficacy," said Steven W. King, president and CEO of Peregrine. "Preclinically, we have now shown that adding bavituximab equivalent antibodies to combination regimens significantly enhances the anti-tumor activity of cancer chemotherapy, of hormone deprivation therapy and of radiation therapy in prostate, breast, lung, brain and pancreatic cancers. The breadth of these potential applications supports many options for future clinical studies."

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is normally located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase Ib trial in advanced cancer patients to assess its safety in combination with common chemotherapy agents, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. A protocol for a Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC) is currently undergoing regulatory review in India. Bavituximab is also in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

This study, entitled "Vascular Targeting Antib
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
11. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Aethlon Medical, Inc. ... definitive agreement to raise approximately $3.3 million at a ... made by one institutional healthcare focused investor. Each unit consists ... a common share purchase warrant. Each whole warrant entitles ... price of $0.30 for a period of five years ...
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... -- BioScrip ® , Inc. (NASDAQ: BIOS ) announced today ... will present at the Bank of America Merrill Lynch 2014 Leveraged ... , , , Wednesday, December 3, 2014 , , , ... , , Location: , , , Boca Raton Resort and Club, ... BioScrip, Inc. is a leading national provider of ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3
... -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded and ... Mr. Hong Zhao, a highly regarded executive in the ... sales and marketing, effective February 12, 2011. ...
... Calif., Feb. 10, 2011 Renaissance Surgical Arts at Newport ... center in the Western United States to offer intraoperative radiotherapy ... in the TARGIT-A multicenter human clinical trial that demonstrated IORT ... with early breast cancer. IORT has the ...
Cached Medicine Technology:Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 2Renaissance Surgical Arts at Newport Harbor Announces Single-Dose Radiation Treatment Alternative for Women with Early Breast Cancer 3
(Date:11/27/2014)... Allowing children to help with chores while they are ... responsibility, ownership, boosts self-esteem, and above all, helps parents maintain ... question is, how do you encourage your children to want ... published by Child Development Journal, there is. The study found ... child’s willingness to lend a hand. , The study ...
(Date:11/27/2014)... Ethane Web Technologies, which is an ... reputation management service. , The company has designed ... world of internet marketing and algorithms of major search ... Web Technologies does not work with the same strategy ... to reach a conclusion what will work for the ...
(Date:11/27/2014)... Viejo, CA, (PRWEB) November 26, 2014 ... their browser-based presentation platform, focused on increasing audience ... by Britannic Technologies. Lintelus’ software platform includes a ... audience and presenter in a collaborative, interactive multi-screen ... meeting and the presentation in real time on ...
(Date:11/26/2014)... 26, 2014 Healthpointe is proud to ... Perris , and it will be led by a ... the field of Occupational Medicine and utilizes the latest ... specialist delivers quality care for employers and their employees, ... , As an Occupational Medicine physician, ...
(Date:11/26/2014)... Sweetdressy.com, the well-known wedding dress manufacturer for the global ... dresses for ladies worldwide. Meanwhile, these graceful items are ... are very popular in the world and clients can ... , Sweetdressy.com believes that a company can attract ... and best services. The spirit of the company is ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Cheap Prom Dresses For Ladies Introduced At SweetDressy.com 2
... DIMAS, Calif., May 19 While scientists ... discovering technologies that will produce super longevity, ... older. Now a new resveratrol-based dietary supplement ... for adults who want to live longer ...
... from an African Man Living with HIV/AIDS Presented to ... President to cut down on the U.S. global health ... AIDS funding is tantamount to genocide, and Mr. Obama ... -- Felix Mwanza, Open Letter to President Obama, May ...
... to train military spouses under the department,s recently expanded CAA education ... ... 2009 -- Career Step , a leading online healthcare education ... military spouses under the department,s recently expanded Career Advancement Account (CAA) ...
... Theravive is pleased to announce expansion into Michigan, ... professional psychotherapists. Psychotherapy and Marriage Counseling ... from a foundation of healthy values with the ... The Theravive network aggressively promotes professional therapists on ...
... Despite the current economic recession, physician and patient demand ... accelerate at healthy rates. Sound Surgical Technologies LLC, ... system during the first quarter of 2009. Further, over ... Each month more than 10,000 patients visit the VASER.com ...
... than Seek to Entrench ItselfOMAHA, Neb., May 18 ... directors and holder of approximately 39% of the outstanding ... today that he strongly disagreed with the Company,s recent ... the Company must explore strategic alternatives."I believe that the ...
Cached Medicine News:Health News:New Longevinex Advantage(R) Designed for Americans Who Want to Live Longer and Look Younger 2Health News:Global Health Advocates Call for Pan-African Voices to Speak Up 2Health News:Global Health Advocates Call for Pan-African Voices to Speak Up 3Health News:Career Step Approved to Train Military Spouses with Department of Defense CAA Funds 2Health News:Theravive.com Expands Values Counseling and Therapy Into Michigan, Florida, and Washington State 2Health News:Theravive.com Expands Values Counseling and Therapy Into Michigan, Florida, and Washington State 3Health News:Sound Surgical Technologies LLC Places 1,000th VASER Lipo System Amongst Strong Patient Demand 2Health News:InfoGroup Founder and Board Member Criticizes Adoption of Poison Pill 2Health News:InfoGroup Founder and Board Member Criticizes Adoption of Poison Pill 3
... Korchek Technologies CareChek ... employs barcode technology, Windows ... with integrated scanners (to ... at the bedside) and ...
... Korchek Technologies CareChek Rx ... barcode technology, Windows CE ... integrated scanners (to perform ... the bedside) and an ...
... care management tools that support the nursing ... vital signs and I&O information at the ... on-line flow sheets. This design supports compliance ... the hall, or at the nursing station, ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell...
Medicine Products: